🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › Nebraska

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Nebraska

8 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa Nebraska.

Mga Lungsod sa Nebraska

Opisyal na teksto ng pag-aaral (English)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • CHI Health Saint Francis, Grand Island
  • CHI Health Good Samaritan, Kearney
  • Alegent Health Immanuel Medical Center, Omaha
  • at 2 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • University of Nebraska Medical Center, Omaha
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06528301

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

  • University of Nebraska Medical Center, Omaha
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277231

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Nagre-recruitPhase 1/2
Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

  • University Of Nebraska Medical Center, Omaha
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  • University Of Nebraska Medical Center, Omaha
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.